Active, Not Recruiting
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
NCT05215574
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
- Locations
-
- NGM Clinical Study Site Gilbert, Arizona, United States
- NGM Clinical Study Site Los Angeles, California, United States
- NGM Clinical Study Site Sarasota, Florida, United States
- NGM Clinical Study Site Tampa, Florida, United States